"As the year winds down, many investors are positioning themselves for 2026 and beyond. Some insiders made big insider purchases while others might be out for the holidays. The year's largest initial public offering prompted a beneficial owner and others to buy into Medline Inc. ( NASDAQ: MDLN). A public offering of Kodiak Sciences Inc. ( NASDAQ: KOD) shares also tempted an insider, and a beneficial owner continues to build a big stake in W.R. Berkley Corp. ( NYSE: WRB)."
"A well-known adage reminds us that corporate insiders and 10% owners really only buy shares of a company because they believe the stock price will rise and they want to profit from it. Thus, insider buying can be an encouraging signal for potential investors. This is especially so during times of market uncertainty, and even when markets are near all-time highs."
Major insider purchases recently included a nearly 17.8 million-share acquisition of Medline by 10% owner GIC Private and two directors at $29 per share, costing about $514.8 million. Each director bought roughly $75 million of shares. Medline plans to use offering proceeds to pay down debt, acquire outstanding equity interests from some pre-IPO owners, and for general corporate purposes. Shares traded above $44, within a range of $34.89 to $45.50. A Kodiak Sciences public offering attracted insider interest, and a beneficial owner continued to build a large stake in W.R. Berkley. Insider buying is presented as an encouraging signal during market uncertainty.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]